Carcinoma, Islet Cell (Keystone)

Islet Cell Carcinoma or Pancreatic Neuroendocrine Tumours arise in the hormone producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on islet cell carcinoma in this feed.

October 25, 2021

A case of pancreatic endocrine carcinoma with a different clinical diagnosis before chemotherapy and pathological autopsy.

Clinical Journal of Gastroenterology
Amane JubashiSeiji Tsunada
October 26, 2021
Review

Translational challenges in pancreatic neuroendocrine tumor immunotherapy.

Biochimica Et Biophysica Acta. Reviews on Cancer
Erika Said Abu EgalEllen J Beswick
October 24, 2021

CAR T-cell entry into tumor islets is a two-step process dependent on IFNγ and ICAM-1.

Cancer Immunology Research
Chahrazade Kantari-MimounEmmanuel Donnadieu
October 19, 2021
Case Report

A Common Concern With a Rare Diagnosis: Pancreatic Neuroendocrine Neoplasms.

Curēus
Ecler JaquaCarlos Cereser
October 15, 2021
Review

Neuroendocrine neoplasms of the pancreas: diagnosis and pitfalls.

Virchows Archiv : an International Journal of Pathology
Björn KonukiewitzGünter Klöppel
October 14, 2021

Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms.

Cell Reports
Kevin C YangSharon M Gorski
October 13, 2021
Open Access

EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs).

Cancers
Simon Leonhard April-MonnIlaria Marinoni
October 11, 2021

miR-320a induces pancreatic β cells dysfunction in diabetes by inhibiting MafF.

Molecular Therapy. Nucleic Acids
Hengzhi DuChen Chen
October 11, 2021
Review

Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies.

World Journal of Gastroenterology : WJG
Roberta Elisa RossiSara Massironi
October 8, 2021

Usefulness of contrast-enhanced endoscopic ultrasonography for the treatment of ethanol reinjection in patient with small pancreatic neuroendocrine neoplasm.

Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society
Kazuyuki MatsumotoHiroyuki Okada
October 8, 2021
Case Report

Primary pancreatic paraganglioma harboring lymph node metastasis: A case report.

World Journal of Clinical Cases
Cui-Nan JiangYu-Qing Xiao
October 8, 2021

[Expression of CD200 and INSM1 in gastrointestinal and pancreatic neuroendocrine neoplasms and its diagnostic values].

Zhonghua bing li xue za zhi Chinese journal of pathology
Z CaoQ L Ao
October 6, 2021

Mechanisms of Immunomodulation and Cytoprotection Conferred to Pancreatic Islet by Human Amniotic Epithelial Cells.

Stem Cell Reviews and Reports
Fanny LebretonEkaterine Berishvili

Sign up to follow this feed and discover related papers.

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Anthracycline Sensitivity & Chromatin (Keystone)

Anthracyclines are used in the treatment of cancer and work by inhibiting topoisomerase II (TOP2). Recent evidence suggests that because DNA accessibility is crucial for TOP2 binding, chromatin regulatory genes should predict anthracycline response. Find the latest research on anthracycline sensitivity and chromatin regulators in this feed.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chemical Tools (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Using novel chemical tools allows us to learn more about these epigenetic changes and how they impact the neoplastic process. Follow this feed to learn more about cancer epigenetics and chemical tools.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

© 2021 Meta ULC. All rights reserved
/feed-previews/carcinoma-islet-cell-keystone/ca5e1c79-5d9d-4839-8388-0e6655b64bfd